Seasonal Evaluation for Edwards Lifesciences Corporation (EW)
The following tables show quarterly and semi-annual reports.
In the quarterly breakdown, the first through fourth quarters correspond to spring, summer, fall, and winter, respectively.
Detailed definitions for the semi-annual periods are provided in the table headers.
| Overview | 1st Quarter Jan. - Mar. |
2nd Quarter Apr. - Jun. |
3rd Quarter Jul. - Sep. |
4th Quarter Oct. - Dec. |
|---|---|---|---|---|
| Success Rate | 70.00% | 70.00% | 55.00% | 60.00% |
| Median Return | 7.70% | 8.92% | 2.67% | 4.60% |
| Average Return | 8.63% | 10.29% | 9.25% | 9.58% |
| Maximum Gain | 25.32% | 42.03% | 20.89% | 24.70% |
| Gain Year | 2024 | 2012 | 2016 | 2014 |
| Maximum Loss | -19.15% | -19.22% | -28.56% | -22.28% |
| Loss Year | 2020 | 2022 | 2024 | 2016 |
| Based on the past 20 years (2006-2025) | ||||
| Overview | Winter Season Oct. - Mar. |
Summer Season Apr. - Sep. |
First HY Jan. - Jun. |
Second HY Jul. - Dec. |
|---|---|---|---|---|
| Success Rate | 65.00% | 62.50% | 70.00% | 57.50% |
| Median Return | 6.85% | 4.14% | 7.85% | 2.94% |
| Average Return | 9.06% | 9.82% | 9.43% | 9.42% |
| Maximum Gain | 25.32% | 42.03% | 42.03% | 24.70% |
| Gain Year | 2024 | 2012 | 2012 | 2014 |
| Maximum Loss | -22.28% | -28.56% | -19.22% | -28.56% |
| Loss Year | 2016 | 2024 | 2022 | 2024 |
| Based on the past 20 years (2006-2025) | ||||